EMIS appoints new MD and announces agreement with NHS Wales

NHS Wales has entered into an agreement, which has a maximum value of £7.6m, with Leeds-based healthcare company EMIS Group’s subsidiary, Ascribe.

The maximum value of the framework agreement, which is to provide a clinical solution to manage unscheduled care in Wales, is approximately £7.6m over the seven-year initial term of the contract, and includes software and hardware, as well as implementation services and ongoing support and maintenance. There is also an option to extend the agreement for a further four years.

This contract will enable the six health boards within NHS Wales to call-off and deploy EMIS Group’s clinical information and management solution, Symphony, into their emergency department and minor injuries units.
 
EMIS also announced this morning that is has appointed Duane Lawrence as managing director of its secondary care division. Mr Lawrence joins EMIS Group from his previous role as chief executive of InferMed, which provides advanced decision support software in healthcare settings across the world.

Chris Spencer, CEO of EMIS Group said: “We welcome this expansion to our long term partnership with NHS Wales and fully support their commitment to improve the provision of Emergency Care services. As well as providing vital information to clinicians in a hospital setting, Symphony will facilitate integration of care by those hospital clinicians and the hundreds of Welsh GPs who already use EMIS Group software.

“We are also delighted that Duane Lawrence is joining us as the managing director of secondary care. His extensive experience in managing healthcare businesses in the UK and internationally will be a valuable addition to the group.”